Followers | 170 |
Posts | 9931 |
Boards Moderated | 3 |
Alias Born | 06/20/2022 |
Tuesday, October 04, 2022 3:57:04 PM
Recent SNTI News
- Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML) • GlobeNewswire Inc. • 04/30/2024 12:05:36 PM
- Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights • GlobeNewswire Inc. • 03/21/2024 08:05:49 PM
- Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program • GlobeNewswire Inc. • 01/05/2024 09:05:00 PM
- Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia • GlobeNewswire Inc. • 12/22/2023 11:30:00 AM
- Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates • GlobeNewswire Inc. • 11/13/2023 09:15:00 PM
- Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China • GlobeNewswire Inc. • 11/06/2023 09:05:00 PM
- Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meeting • GlobeNewswire Inc. • 10/31/2023 01:06:00 PM
- Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer 2023 Meeting • GlobeNewswire Inc. • 09/27/2023 01:05:00 PM
- Senti Bio to Participate in Upcoming Conferences • GlobeNewswire Inc. • 09/26/2023 08:05:00 PM
- Senti Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 09/05/2023 12:30:00 PM
- Senti Bio Announces Second Quarter 2023 Results and Pipeline Updates • GlobeNewswire Inc. • 08/11/2023 12:35:00 PM
- Senti Bio Announces Closing of Transaction Leveraging its CMC Capabilities into a Cell and Gene Therapy Manufacturing Innovation Business Backed by Celadon Partners • GlobeNewswire Inc. • 08/10/2023 12:35:00 PM
- Senti Bio Highlights Initial Gene Circuit Data From Collaborations at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting • GlobeNewswire Inc. • 05/20/2023 12:05:00 PM
- Senti Bio Announces First Quarter 2023 Results and Pipeline Updates • GlobeNewswire Inc. • 05/09/2023 08:05:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM